Crowdonomics
WatchlistPortfolio
All companies
O2 Pure Hydration logo

O2 Pure Hydration

Operating

O2, Inc.

Food & Beverage · Packaged Drink · Founded 2021

Visit website

Super-oxygenated sports beverage company

Post-money valuation ⓘ
$26.4M
As of Apr 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$1,072,084
Crowd $935K · Private $137K · 2 rounds since 2022
Latest share price
$115.6508
Reg CF · Preferred Stock · Jan 2022 offering price

Financials

FY2019–FY2025 · from SEC filings · hover any figure for its source
$1.6M
−$1.9M
2019
2020
$3.6M
−$1.6M
2021
$2.9M
−$4.1M
2022
$3.0M
−$332K
2023
$2.4M
−$1.1M
2024
$1.6M
−$711K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 audited
FY2020 audited
FY2021
FY2022 unaudited
FY2023 unaudited
FY2024
FY2025
Income statement
Revenue
$1,582,598
—
$3,565,771
$2,852,888
$3,012,946
$2,377,329
$1,624,403
Cost of goods sold
$337,358
—
$1,501,332
$1,335,403
$1,239,627
$715,172
$447,556
Gross margin
79%
—
58%
53%
59%
70%
72%
Net income
-$1,924,710
—
-$1,567,754
-$4,118,404
-$331,979
-$1,063,145
-$711,383
Taxes paid
$0
—
$0
$0
$0
$0
$0
Balance sheet
Cash
$368,933
—
$724,982
$204,565
$1,112,234
$101,404
$118,538
Accounts receivable
$81,007
—
$50,531
$61,119
$0
$0
$121,092
Total assets
$1,410,961
—
$1,727,203
$1,267,778
$1,121,052
$716,932
$646,154
Short-term debt
$749,355
—
$1,373,099
$1,090,961
$80,293
$597,878
$508,548
Long-term debt
$500,000
—
$1,266,073
$3,323,615
$0
$0
$7,437,455
Total liabilities
$1,249,355
—
$2,639,172
$4,414,576
$80,293
$597,878
$7,946,003
Other
Headcount
—
8
—
10
5
5
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$25.0M
pre-money
Reg CF · Preferred · Jan 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Fundraising history

Reg CF · Preferred Stock · Jan 2022Closedvia Netcapital
Raised $935.3K / $3.5MInvestors 551Post-money $26.4M
Rule 506(b) · Equity · Feb 2022Closed
Raised $136.8KInvestors 10

Team

7 people
David ColinaFounder
Founder & CEO
Dr. Daniel Kim
Chief Medical Officer
Dan Crane
Board of Directors Member
James Lyski
Board of Directors Member
Jeffrey Rosenblum
Board of Directors Member
Katrina Hahn
Board of Directors Member
Stephanie Fortener
Board of Directors Member

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not required3+ reports filed & assets ≤ $10M

Filed 5 of 5 annual reports (FY2021–FY2025)

551 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 12 filings on EDGAR
  • Form C-ARMay 13, 20260001902033-26-000009
    EDGAR
  • Form C-ARApr 29, 20260001902033-26-000005
    EDGAR
  • Form C-ARJan 10, 20250001665160-25-000043
    EDGAR
  • Form C-ARJul 26, 20230001099910-23-000143
    EDGAR
  • Form C-ARMay 11, 20220001902033-22-000007
    EDGAR
  • Form C-UMay 9, 20220001902033-22-000006
    EDGAR
  • Form C-UMay 4, 20220001902033-22-000005
    EDGAR
  • Form C-UApr 21, 20220001902033-22-000004
    EDGAR
Source: ManualCIK 0001902033Share price $115.6508

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.